FeesSafety
Pluang+

Dave's Hot Chicken launches limited-time Pepper X spice, the world's hottest chili pepper.

Others
11 Nov 2026, 22:33 WIB
Globe News Wire
View Source
Bullish
Dave's Hot Chicken launches limited-time Pepper X spice, the world's hottest chili pepper.

Dave's Hot Chicken has introduced a new limited-time spice blend featuring Pepper X, recognized by Guinness World Records as the world's hottest chili pepper at 2.7 million Scoville units. Developed by PuckerButt Pepper Company and created by chili breeder "Smokin' Ed" Currie, Pepper X surpasses the brand's legendary Reaper pepper in heat. This new spice level offers fans an extreme heat challenge and is available on various menu items nationwide, while the Reaper spice remains a permanent option. The launch highlights Dave's commitment to pushing flavor boundaries and catering to heat enthusiasts.

Dave's Hot Chicken's new world-record Pepper X spice is the story's subject, with this market context for readers following Consumer Cyclical stocks on Pluang. As of Nov 12, 2026 02:31 WIB, out of 134 priced US Consumer Cyclical-sector stocks, 45 rose and 86 fell. Notable movers include JMIA at USD 5.72 (+3.62%), MBLY at USD 5.82 (+3.37%), and TSLA at USD 392.59 (+3.37%) with a typical hold time of 89 days and Pluang order activity showing 81% Sell and 19% Buy.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
2 hours ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
2 hours ago
Nvidia remains attractively valued at 11x FY 2028 earnings despite short-term risks from China and AI cycles.

Nvidia remains attractively valued at 11x FY 2028 earnings despite short-term risks from China and AI cycles.

Nvidia Corporation is currently trading at a reasonable valuation of 11 times its projected earnings for fiscal year 2028, reflecting strong financial and operational growth since mid-2025. While regulatory and geopolitical risks, especially related ...

Analyst Insights
Bullish
5 hours ago
Bitcoin risks first-ever back-to-back yearly losses, down 16.5% in 2026 after a slight 2025 drop.

Bitcoin risks first-ever back-to-back yearly losses, down 16.5% in 2026 after a slight 2025 drop.

Bitcoin is on track to record consecutive yearly losses for the first time in its 18-year history, with a 6.34% drop in 2025 followed by a 16.5% decline so far in 2026. Prominent critic Peter Schiff highlighted this unusual trend, warning it could le...

Market News
Bearish
5 hours ago
Tron Inc. posts $14.9M Q3 net income, up 22%, with digital assets at $257.8M and growing TRX treasury.

Tron Inc. posts $14.9M Q3 net income, up 22%, with digital assets at $257.8M and growing TRX treasury.

Tron Inc. reported a net income of $14.9 million for Q3 2026, marking a 22% increase from $12.2 million a year earlier. For the first nine months of 2026, net income surged about 203% to $39.4 million. The company held $257.8 million in digital-asset...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App